Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Early Recalls and Clinical Validation Gaps in Artificial Intelligence–Enabled Medical Devices
3
Zitationen
9
Autoren
2025
Jahr
Abstract
This cross-sectional study examines whether lack of clinical validation and publicly traded manufacturer status were associated with recalls of artificial intelligence–enabled medical devices that had been cleared by the US Food and Drug Administration.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.521 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.412 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.891 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.575 Zit.